Sulfotransferase SULT2B1 facilitates colon cancer metastasis by promoting SCD1‐mediated lipid metabolism
Clinical and Translational Medicine · 2024-02 · 14 (2)
DOI: 10.1002/ctm2.1587 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Medicine, online erschienen am 19.02.2024. Verfasst von Gang Che und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Lipid Metabolism, Colonic Neoplasms. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key R & D projects, Zhejiang Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Metastasis is responsible for at least 90% of colon cancer (CC)‐related deaths. Lipid metabolism is a critical factor in cancer metastasis, yet the underlying mechanism requires further investigation. Herein, through the utilisation of single‐cell sequencing and proteomics, we identified sulfotransferase SULT2B1 as a novel metastatic tumour marker of CC, which was associated with poor prognosis. CC orthotopic model and in vitro assays showed that SULT2B1 promoted lipid metabolism and metastasis. Moreover, SULT2B1 directly interacted with SCD1 to facilitate lipid metabolism and promoted metastasis of CC cells. And the combined application of SCD1 inhibitor CAY with SULT2B1‐ konockout (KO) demonstrated a more robust inhibitory effect on lipid metabolism and metastasis of CC cells in comparison to sole application of SULT2B1‐KO. Notably, we revealed that lovastatin can block the SULT2B1‐induced promotion of lipid metabolism and distant metastasis in vivo. Further evidence showed that SMC1A transcriptionally upregulated the expression of SULT2B1. Our findings unveiled the critical role of SULT2B1 in CC metastasis and provided a new perspective for the treatment of CC patients with distant metastasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgical Oncology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
- Center Laboratory, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
- Department of Colorectal Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
- Department of Thoracic Surgery, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
- Department of Colorectal Medicine, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China.
Förderung
- Key R & D projects, Zhejiang Province
- National Natural Science Foundation of China
Zitieren
APA
Che, G., Wang, W., Wang, J., He, C., Yin, J., Chen, Z., He, C., Wang, X., Yang, Y., & Liu, J. (2024). Sulfotransferase SULT2B1 facilitates colon cancer metastasis by promoting SCD1‐mediated lipid metabolism. Clinical and Translational Medicine, 14(2). https://doi.org/10.1002/ctm2.1587
Vancouver
Che G, Wang W, Wang J, He C, Yin J, Chen Z, et al. Sulfotransferase SULT2B1 facilitates colon cancer metastasis by promoting SCD1‐mediated lipid metabolism. Clinical and Translational Medicine. 2024;14(2). doi:10.1002/ctm2.1587
BibTeX
@article{Che2024,
author = {Che, Gang and Wang, Wankun and Wang, Jiawei and He, Cheng and Yin, Jie and Chen, Zhendong and He, Chao and Wang, Xujing and Yang, Yan and Liu, Jian},
title = {Sulfotransferase SULT2B1 facilitates colon cancer metastasis by promoting SCD1‐mediated lipid metabolism},
journal = {Clinical and Translational Medicine},
year = {2024},
volume = {14},
number = {2},
doi = {10.1002/ctm2.1587}
}
EUVIMED